Article
CYP7A1 polymorphism influences the LDL cholesterol-lowering response to atorvastatin.
Journal of clinical pharmacy and therapeutics - 1 Dec 2012
Jiang X-Y, Zhang Q, Chen P, Li S-Y, Zhang N-N, Chen X-D, Wang G-C, Wang H-B, Zhuang M-Q, Lu M
Abstract excerpt
WHAT IS KNOWN AND OBJECTIVE: Response to the lipid-lowering effect of the statins is known to show significant inter-individual variability. Our aim was to investigate whether genetic variants of the CYP3A5 gene, CYP7A1 gene and ABCG8 gene influence the lipid-lowering response to atorvastatin. METHODS: One hundred and seven unrelated Chinese Han hypercholesterolemia patients were recruited from among the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
